Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now early-phase tilt small index

Puberty: early-phase trial registry

8 of 9 indexed Puberty trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 8 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Puberty: 9 US clinical trials tracked, 8 recruiting.

Puberty is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of Virginia, running 3 of these trials.

Enrollment posture brief

Registry condition puberty

OPEN 8 | RECR 89% | LATE 0 | EARLY 3 | RANK #1916 | SPON 3

Nearest open-share peer: Acute Spinal Cord Injury (89% recruiting · 9 trials)

Puberty (this)89%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Puberty

Puberty lists 8 open slots (89% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Puberty on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Puberty is recruiting above its size-band peers.

    8 of 9 indexed trials (88.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Puberty research.

    University of Virginia accounts for 3 of 9 trials (33.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Puberty trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.

  4. Puberty splits between interventional and observational designs.

    6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13

Phase Distribution

PhaseTrial count
Phase 1 3

Named interventions

Most-linked intervention names on Puberty records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
Spironolactone Drug
2 trials
GnRH Agonist Device
1 trials
ActiveGirls Physical Activity Program (Delayed Lower Intensity) Behavioral
1 trials
ActiveGirls Physical Activity Program (Full) Behavioral
1 trials
Micronized progesterone Drug
1 trials
Dextran 40 Drug
1 trials
Iohexol Inj 300 MG/ML Drug
1 trials

US sites by state

Facility locations filed on Puberty trials. A trial with sites in several states counts in each.

Virginia 3 trials
Missouri 2 trials
Massachusetts 2 trials
Washington 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Puberty page

9 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Puberty condition card totals 9 registered trials; most-linked intervention Placebo; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.